160 related articles for article (PubMed ID: 29520101)
21. Effect and Mechanism of Cotrimoxazole Against Talaromyces marneffei in vitro.
Chen J; Chen R; Wei W; Qin F; Chen X; He J; Zhang H; Wang G; Shi M; Qin T; Liao Y; Wu Y; Lu B; Tao X; Ye L; Liang H; Jiang J
Mycopathologia; 2022 Dec; 187(5-6):579-593. PubMed ID: 36318375
[TBL] [Abstract][Full Text] [Related]
22. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
23. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
24. Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease.
Prado D; López E; Liu H; Devoto S; Woloj M; Contrini M; Murray BE; Gómez H; Cleary TG
Pediatr Infect Dis J; 1992 Aug; 11(8):644-7. PubMed ID: 1523076
[TBL] [Abstract][Full Text] [Related]
25. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
[TBL] [Abstract][Full Text] [Related]
26. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
[TBL] [Abstract][Full Text] [Related]
27. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
28. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
29. Anti-fungal activity of sulfamethoxazole toward Aspergillus species.
Hida S; Yoshida M; Nakabayashi I; Miura NN; Adachi Y; Ohno N
Biol Pharm Bull; 2005 May; 28(5):773-8. PubMed ID: 15863877
[TBL] [Abstract][Full Text] [Related]
30. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
31. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility of equine Salmonella strains to trimethoprim and sulfonamide alone or in combination.
van Duijkeren E; van Klingeren B; Vulto AG; Sloet van Oldruitenborgh-Oosterbaan MM; Breukink HJ; van Miert AS
Am J Vet Res; 1994 Oct; 55(10):1386-90. PubMed ID: 7998695
[TBL] [Abstract][Full Text] [Related]
34. Virgin coconut oil protects against liver damage in albino rats challenged with the anti-folate combination, trimethoprim-sulfamethoxazole.
Otuechere CA; Madarikan G; Simisola T; Bankole O; Osho A
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):249-53. PubMed ID: 24285126
[TBL] [Abstract][Full Text] [Related]
35. Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression.
Moon KH; Weber BS; Feldman MF
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674047
[No Abstract] [Full Text] [Related]
36. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
Harding GK; Ronald AR; Boutros P; Lank B
Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
[TBL] [Abstract][Full Text] [Related]
37. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
38. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE
AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401
[TBL] [Abstract][Full Text] [Related]
40. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
